May 7, 2026 11:58 AM

Moderna’s mRNA flu vaccine outperforms standard shot in late-stage trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on Wednesday. The vaccine is currently under review by the U.S. Food and Drug Administration after the agency rejected the company's initial application. A decision is expected by August 5. If approved, Moderna's shot would be the first seasonal flu shot in the United States made with mRNA technology, a faster...

July 11, 2024 5:44 PM

Musk’s Neuralink says tiny wires of brain chip in first patient now stable

The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a company executive said on Wednesday. The company had in May said that a number of tiny wires inside the brain of Noland Arbaugh, who is paralyzed from the shoulders down due to a 2016 diving accident, had pulled out of position. "Once you do the brain surgery it takes some time for the tissues to come in and anchor the threads in place, ...